Deerfield Management’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
Other funds holding XENT
MF
VI
FLAM
AAM
RSCM
Deerfield Management's XENT Position: Q3 2021 in Review
Deerfield Management sold out of Intersect ENT, Inc (XENT) in Q3 2021, closing a stake of 255,456 shares — an estimated $4.37M sold.
Deerfield Management first reported a position in XENT in Q2 2017 and held it in 17 quarters. The position peaked at $70.8M in Q2 2019. 123 funds tracked by Wall St. Rank hold XENT as of Q3 2021.
- Deerfield Management reported no remaining Intersect ENT, Inc position as of Q3 2021 after selling out during the quarter.
- Deerfield Management sold 255,456 Intersect ENT, Inc shares in Q3 2021, an estimated $4.37M.
- Deerfield Management first reported a position in Intersect ENT, Inc in Q2 2017 and held it in 17 quarters.
- Deerfield Management's Intersect ENT, Inc position peaked at $70.8M in Q2 2019.
- 123 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2021.
Based on Deerfield Management's 13F filing for Q3 2021, filed 15 Nov 2021.